953778-63-7
Chemical Structure
TTA-A2
- CAS No.: 953778-63-7
- Formula:C20H21F3N2O2
- Molecular Weight:378.39
IUPAC Name: (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
InChIKey: GEYDMBNDOVPFJL-CYBMUJFWSA-N
SMILES: O=C(N[C@@H](C1=NC=C(OCC(F)(F)F)C=C1)C)CC2=CC=C(C3CC3)C=C2
Biological Activity: TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TTA-A2 | 99.33% | TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
TTA-A2 (Standard) | ≥98% | TTA-A2 (Standard) is the analytical standard of TTA-A2 (HY-111828). This product is intended for research and analytical applications. TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.83
HY-101096Suvecaltamide -
Similarity Score 0.70
HY-14232TTA-A8 -
Similarity Score 0.51
HY-180468Kv7 activator-2 -
Similarity Score 0.49
HY-186246TUG-2304 -
Similarity Score 0.48
HY-Z8178Flecainide Impurity 3 -
Similarity Score 0.48
HY-117118AAC-90179 -
Similarity Score 0.48
HY-100688RML390 (Standard) -
Similarity Score 0.48
HY-120057CP-331684 -
Similarity Score 0.48
HY-180464Kv7.2/Kv7.3 modulator-3 -
Explore the MedChemAI to find more analogs
